United Therapeutics Corporation (UTHR) Put/Call Volume History
Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.
United Therapeutics Corporation (UTHR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $24.60B, listed on NASDAQ, employing roughly 1,305 people, carrying a beta of 0.59 to the broader market. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Led by Martine A. Rothblatt, public since 1999-06-17.
Snapshot as of May 15, 2026.
- Spot Price
- $567.93
- Call Volume
- 395
- Put Volume
- 36
- Total Volume
- 431
- Put/Call Ratio
- 0.09
As of May 15, 2026, United Therapeutics Corporation (UTHR) traded 431 total options contracts. Volume split was 395 calls and 36 puts. Put/call volume ratio is 0.09. Elevated flow relative to the ticker's recent average can signal institutional positioning, pending news, earnings expectations, or hedging activity. Daily volume is the most responsive short-term gauge of changing demand.
How UTHR put/call volume history Data Feeds Strategy Selection
Strategy selection on United Therapeutics Corporation options does not derive from any single metric in isolation. The put/call volume history view above sits inside a broader read: ATM IV currently sits at 32.7% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the put/call volume history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how options volume is reported and how to read the data →
UTHR most-active contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $620.00 | Aug 21, 2026 | 0 | 5.7K | 33.1% | $18.30 | $26.00 |
| PUT | $530.00 | Aug 21, 2026 | 1 | 5.7K | 34.9% | $17.70 | $23.70 |
| CALL | $660.00 | Aug 21, 2026 | 2 | 5.7K | 32.6% | $9.10 | $16.00 |
Top 3 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.
Frequently asked UTHR put/call volume history questions
- How much UTHR options volume traded today?
- As of May 15, 2026, United Therapeutics Corporation (UTHR) traded 431 total options contracts, split as 395 calls and 36 puts. Volume measures today's flow only; standing inventory is captured by open interest, which reconciles after the close.
- What is the UTHR put/call volume ratio?
- As of May 15, 2026, the put/call volume ratio is 0.09. Equity-only PCR has three competing interpretations - sentiment-contrarian (extremes signal turning points), hedging-flow (high PCR can be portfolio insurance demand rather than bearish bets), and informed-flow (the volume signal carries short-horizon predictive content per Pan and Poteshman 2006). Resolving which frame applies requires context on whether the flow is opening or closing and which strikes carry the activity.
- Is UTHR options volume elevated?
- Elevated flow relative to the UTHR recent average is one of the strongest signals of institutional positioning, pending news, earnings expectations, or hedging activity. The most informative reads combine elevated volume with directional structure (single-leg or vertical), aggressive execution (at the ask or sweep), and an upcoming catalyst on the calendar.